BioPharma Dive November 21, 2025
The pharmaceutical company’s success developing medicines for obesity has swelled its worth to levels associated with tech titans like Apple and Google.
Eli Lilly, the pharmaceutical company founded nearly 150 years ago by a Civil War veteran of the same name, on Friday briefly became the first drugmaker to reach $1 trillion in market value.
The milestone is the result of a vertiginous rise in Lilly’s stock price that stems from its success developing drugs for obesity. Shares, worth under $100 as recently as 2018, now trade for more than 10 times that much.
The rapid growth reflects Lilly’s newfound position at the center of treatment for two of this century’s most widespread, and to date intractable, medical conditions. Zepbound,...
Today's Sponsors
Today's Sponsor